Preventing Retaliatory Gun Violence in Violently Injured Adults
Launched by VIRGINIA COMMONWEALTH UNIVERSITY · Mar 23, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a program called "Bridging the Gap," which aims to reduce violence among adults who have been treated for injuries caused by violence, such as gunshot wounds. The researchers believe that those who participate in this program will experience a greater decrease in violent behaviors compared to those who do not take part in the program. The study will also explore whether this intervention influences other risky behaviors, like using guns, drugs, or engaging in aggressive actions.
To be eligible for this study, participants must be at least 18 years old, speak English, and have been treated at the hospital for a violence-related injury. They should also live in specific areas around Richmond City. If someone qualifies and chooses to participate, they can expect support through the intervention to help improve their situation and reduce the chances of future violence. The trial is currently recruiting participants, and it could provide valuable insights into preventing violent behaviors and improving safety in the community.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • They receive treatment in the hospital for a violence-related injury (e.g., gunshot wound)
- • They are 18 years or older
- • They are English speaking
- • They are eligible for BTG services (which includes living within the BTG catchment area for the hospital; Richmond City and neighboring counties)
- Exclusion Criteria:
- • Non-English speaking
- • Age \<18
- • Prisoners
About Virginia Commonwealth University
Virginia Commonwealth University (VCU) is a prominent academic institution and research leader located in Richmond, Virginia. Renowned for its commitment to advancing healthcare through innovative research and education, VCU plays a pivotal role in clinical trials aimed at improving patient outcomes and understanding complex health issues. The university boasts a collaborative environment, leveraging its diverse faculty expertise and state-of-the-art facilities to conduct rigorous clinical research across various medical disciplines. VCU's dedication to ethical research practices and community engagement ensures that its clinical trials are designed to address critical health challenges while prioritizing participant safety and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Richmond, Virginia, United States
Patients applied
Trial Officials
Nicholas Thomson
Principal Investigator
Virginia Commonwealth University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials